The GSTO2 (rs156697) Polymorphism Modifies Diabetic Nephropathy Risk.

MLA

Pavlovic, Dragana, et al. “The GSTO2 (Rs156697) Polymorphism Modifies Diabetic Nephropathy Risk.” Medicina (1010660X), vol. 59, no. 1, Jan. 2023, p. 164. EBSCOhost, https://doi.org/10.3390/medicina59010164.

APA

Pavlovic, D., Ristic, S., Djukanovic, L., Matic, M., Kovacevic, M., Pljesa-Ercegovac, M., Hadzi-Djokic, J., Savic-Radojevic, A., & Djukic, T. (2023). The GSTO2 (rs156697) Polymorphism Modifies Diabetic Nephropathy Risk. Medicina (1010660X), 59(1), 164. https://doi.org/10.3390/medicina59010164

Chicago

Pavlovic, Dragana, Sinisa Ristic, Ljubica Djukanovic, Marija Matic, Marijana Kovacevic, Marija Pljesa-Ercegovac, Jovan Hadzi-Djokic, Ana Savic-Radojevic, and Tatjana Djukic. 2023. “The GSTO2 (Rs156697) Polymorphism Modifies Diabetic Nephropathy Risk.” Medicina (1010660X) 59 (1): 164. doi:10.3390/medicina59010164.